Viewing Study NCT02830750


Ignite Creation Date: 2025-12-24 @ 5:07 PM
Ignite Modification Date: 2026-02-06 @ 4:23 PM
Study NCT ID: NCT02830750
Status: COMPLETED
Last Update Posted: 2018-04-26
First Post: 2016-06-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Low Fluoroscopy Afib Ablation Registry
Sponsor: Stanford University
Organization:

Study Overview

Official Title: A Multi Center Registry of Low- Fluoroscopy Atrial Fibrillation Ablation Using Electroanatomic Mapping Carto
Status: COMPLETED
Status Verified Date: 2018-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Prospective data collection of patients undergoing Atrial Fibrillation Ablation.
Detailed Description: Clinicians who have experience using low dose fluoroscopy including use of Carto Mapping system will consent patients to allow data collection and a 12 month f/up visit to track adverse events. Clinicians will follow a protocol which will be similar to their standard of care for ablations.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: